secwatch.observer — SEC 8-K summary
======================================

Issuer:     Celularity Inc (CELU)
CIK:        0001752828
Form:       8-K
Filed at:   2025-08-18T23:59:59+00:00
Accession:  0001641172-25-024623
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Celularity retires all $41.6M senior secured debt via IP sale and license-back deal
--------------------------------------------------------------------------------

- Retired all $32M principal plus $9.6M accrued interest on senior secured loans for total $41.6M.
- Sold IP assets to Celeniv for $33,812,230; licensed back exclusively with five-year repurchase option.
- Created four operating subsidiaries for advanced biomaterials, longevity cell therapy, biobanking, and CDMO.
- Proceeds used to retire $27M RWI loan and $6,812,230 promissory note; prior note proceeds retired C.V. Starr loan.
- Retained exclusive use of IP; balance sheet improved with removal of general security interest.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1752828/000164117225024623/0001641172-25-024623-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1752828/000164117225024623/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-024623

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer